CA2928185C - Method for improving the sensitivity of detection in determining copy number variations - Google Patents

Method for improving the sensitivity of detection in determining copy number variations Download PDF

Info

Publication number
CA2928185C
CA2928185C CA2928185A CA2928185A CA2928185C CA 2928185 C CA2928185 C CA 2928185C CA 2928185 A CA2928185 A CA 2928185A CA 2928185 A CA2928185 A CA 2928185A CA 2928185 C CA2928185 C CA 2928185C
Authority
CA
Canada
Prior art keywords
sequence
coverage
sample
bin
interest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2928185A
Other languages
English (en)
French (fr)
Other versions
CA2928185A1 (en
Inventor
Darya I. Chudova
Diana ABDUEVA
Richard P. Rava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Verinata Health Inc
Original Assignee
Verinata Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verinata Health Inc filed Critical Verinata Health Inc
Publication of CA2928185A1 publication Critical patent/CA2928185A1/en
Application granted granted Critical
Publication of CA2928185C publication Critical patent/CA2928185C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CA2928185A 2013-10-21 2014-10-21 Method for improving the sensitivity of detection in determining copy number variations Active CA2928185C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361893830P 2013-10-21 2013-10-21
US61/893,830 2013-10-21
PCT/US2014/061635 WO2015061359A1 (en) 2013-10-21 2014-10-21 Method for improving the sensitivity of detection in determining copy number variations

Publications (2)

Publication Number Publication Date
CA2928185A1 CA2928185A1 (en) 2015-04-30
CA2928185C true CA2928185C (en) 2024-01-30

Family

ID=51894216

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2928185A Active CA2928185C (en) 2013-10-21 2014-10-21 Method for improving the sensitivity of detection in determining copy number variations

Country Status (9)

Country Link
US (1) US10741269B2 (https=)
EP (2) EP3061021B1 (https=)
JP (1) JP6534191B2 (https=)
KR (2) KR102429186B1 (https=)
CN (1) CN105830077B (https=)
AU (2) AU2014340239B2 (https=)
CA (1) CA2928185C (https=)
IL (1) IL245177B (https=)
WO (1) WO2015061359A1 (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1206055A1 (en) 2012-03-02 2015-12-31 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
CN105190656B (zh) 2013-01-17 2018-01-16 佩索纳里斯公司 用于遗传分析的方法和系统
HK1216655A1 (zh) 2013-03-13 2016-11-25 Sequenom, Inc. 用於dna甲基化分析的引物
KR102429186B1 (ko) 2013-10-21 2022-08-03 베리나타 헬스, 인코포레이티드 사본수 변동을 결정함에 있어서 검출의 감수성을 향상시키기 위한 방법
US11365447B2 (en) 2014-03-13 2022-06-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2950596C (en) * 2014-05-30 2023-10-31 Verinata Health, Inc. Detecting fetal sub-chromosomal aneuploidies and copy number variations
ES2741400T3 (es) 2014-07-18 2020-02-10 Univ Hong Kong Chinese Análisis de patrones de metilación de tejidos en mezcla de ADN
US10892035B2 (en) * 2014-10-10 2021-01-12 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10125399B2 (en) 2014-10-30 2018-11-13 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
WO2016081712A1 (en) * 2014-11-19 2016-05-26 Bigdatabio, Llc Systems and methods for genomic manipulations and analysis
EP3502273B1 (en) * 2014-12-12 2020-07-08 Verinata Health, Inc. Cell-free dna fragment
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
US10733476B1 (en) * 2015-04-20 2020-08-04 Color Genomics, Inc. Communication generation using sparse indicators and sensor data
EP3118324A1 (en) * 2015-07-13 2017-01-18 Cartagenia N.V. Method for analyzing copy number variation in the detection of cancer
BE1023266B1 (nl) * 2015-07-13 2017-01-17 Cartagenia N.V. Systeem en methodologie voor de analyse van genomische gegevens die zijn verkregen van een onderwerp
BE1023267B1 (nl) * 2015-07-13 2017-01-17 Cartagenia N.V. Werkwijze voor het analyseren van kopienummervariatie bij de detectie van kanker
US10095831B2 (en) 2016-02-03 2018-10-09 Verinata Health, Inc. Using cell-free DNA fragment size to determine copy number variations
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
US20190287645A1 (en) * 2016-07-06 2019-09-19 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
MX2019003344A (es) * 2016-09-22 2019-09-04 Illumina Inc Deteccion de variacion de numero de copias somaticas.
EP3518974A4 (en) * 2016-09-29 2020-05-27 Myriad Women's Health, Inc. NON-INVASIVE PRENATAL SCREENING USING DYNAMIC ITERATIVE DEEP OPTIMIZATION
WO2018099418A1 (en) 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
EP3559841B1 (en) * 2016-12-22 2025-08-06 Grail, Inc. Base coverage normalization and use thereof in detecting copy number variation
CA3046007A1 (en) 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
CN116612818A (zh) * 2017-01-06 2023-08-18 伊鲁米那股份有限公司 移相校正
US11929143B2 (en) 2017-01-20 2024-03-12 Sequenom, Inc Methods for non-invasive assessment of copy number alterations
KR101957909B1 (ko) 2017-02-24 2019-03-15 에스디지노믹스 주식회사 복제수 변이 후보 우선순위 연산 방법
WO2018170443A1 (en) * 2017-03-16 2018-09-20 Counsyl, Inc. Multi-dimensional sample-dependent and batch-dependent quality control
US11342047B2 (en) 2017-04-21 2022-05-24 Illumina, Inc. Using cell-free DNA fragment size to detect tumor-associated variant
CN108733982B (zh) * 2017-09-26 2021-02-19 上海凡迪基因科技有限公司 孕妇nipt结果校正方法、装置及计算机可读存储介质、设备
NZ759171A (en) 2017-11-16 2022-05-27 Illumina Inc Systems and methods for determining microsatellite instability
WO2019178289A1 (en) * 2018-03-13 2019-09-19 Grail, Inc. Method and system for selecting, managing, and analyzing data of high dimensionality
CN119753091A (zh) 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
CN108647492B (zh) * 2018-05-02 2019-04-16 中国人民解放军军事科学院军事医学研究院 一种染色质拓扑相关结构域的表征方法及装置
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
CN112888459B (zh) 2018-06-01 2023-05-23 格里尔公司 卷积神经网络系统及数据分类方法
IL281741B2 (en) 2018-09-27 2026-04-01 Grail Inc Methylation markers and a targeted methylation detection panel
GB2577548B (en) 2018-09-28 2022-10-26 Siemens Healthcare Gmbh Method for determining a subject's genetic copy number value
KR102215151B1 (ko) 2018-09-28 2021-02-10 한양대학교 산학협력단 다중 참조 유전체에 기반한 유전체 구조변이 검출 방법 및 구조변이 검출 장치
CN111028888B (zh) * 2018-10-09 2024-07-16 北京贝瑞和康生物技术有限公司 一种全基因组拷贝数变异的检测方法及其应用
UY38479A (es) 2018-11-19 2020-06-30 Sist Genomicos S L Método y producto informático de análisis de adn fetal por secuenciación masiva
CN109754845B (zh) * 2018-12-29 2020-02-28 浙江安诺优达生物科技有限公司 模拟目标疾病仿真测序文库的方法及其应用
CN109887546B (zh) * 2019-01-15 2019-12-27 明码（上海）生物科技有限公司 基于二代测序的单基因或多基因拷贝数检测系统及方法
CN112823391B (zh) * 2019-06-03 2024-07-05 Illumina公司 基于检测限的质量控制度量
EP4035161A1 (en) 2019-09-23 2022-08-03 Grail, LLC Systems and methods for diagnosing a disease condition using on-target and off-target sequencing data
US11891653B2 (en) 2019-09-30 2024-02-06 Guardant Health, Inc. Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
EP4055610A4 (en) 2019-11-05 2023-11-29 Personalis, Inc. ESTIMATION OF TUMOR PURITY FROM SINGLE SAMPLES
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US12234518B2 (en) 2020-10-23 2025-02-25 Guardant Health, Inc. Compositions and methods for analyzing DNA using partitioning and base conversion
EP4413580A4 (en) 2021-10-05 2025-08-13 Personalis Inc PERSONALIZED TESTS FOR PERSONALIZED CANCER MONITORING
CN121368638A (zh) * 2023-06-30 2026-01-20 因美纳有限公司 在测序运行期间修改测序循环或成像以满足定制的覆盖度估计
CN117524301B (zh) * 2024-01-04 2024-04-09 北京泛生子基因科技有限公司 一种拷贝数变异的检测方法、装置以及计算机可读介质

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US7601499B2 (en) 2005-06-06 2009-10-13 454 Life Sciences Corporation Paired end sequencing
US9163229B2 (en) 2006-10-10 2015-10-20 Trovagene, Inc. Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
LT2557517T (lt) * 2007-07-23 2023-01-10 The Chinese University Of Hong Kong Nukleino rūgščių sekos disbalanso nustatymas
AU2008308457A1 (en) 2007-10-04 2009-04-09 Halcyon Molecular Sequencing nucleic acid polymers with electron microscopy
WO2009051842A2 (en) 2007-10-18 2009-04-23 The Johns Hopkins University Detection of cancer by measuring genomic copy number and strand length in cell-free dna
HUE031848T2 (en) 2008-09-20 2017-08-28 Univ Leland Stanford Junior Non-invasive diagnosis of fetal aneuploidy by sequencing
EA034241B1 (ru) * 2009-11-06 2020-01-21 Те Чайниз Юниверсити Ов Гонконг Способ пренатальной диагностики дисбаланса последовательности
EP2526415B1 (en) 2010-01-19 2017-05-03 Verinata Health, Inc Partition defined detection methods
US9260745B2 (en) 2010-01-19 2016-02-16 Verinata Health, Inc. Detecting and classifying copy number variation
WO2012006291A2 (en) 2010-07-06 2012-01-12 Life Technologies Corporation Systems and methods to detect copy number variation
US9029103B2 (en) 2010-08-27 2015-05-12 Illumina Cambridge Limited Methods for sequencing polynucleotides
US8725422B2 (en) 2010-10-13 2014-05-13 Complete Genomics, Inc. Methods for estimating genome-wide copy number variations
MX349568B (es) * 2010-11-30 2017-08-03 Univ Hong Kong Chinese Deteccion de aberraciones geneticas o moleculares asociadas con el cancer.
AU2011365507A1 (en) * 2011-04-14 2013-05-02 Verinata Health, Inc. Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies
US9411937B2 (en) 2011-04-15 2016-08-09 Verinata Health, Inc. Detecting and classifying copy number variation
JP5926795B2 (ja) 2011-05-31 2016-05-25 ベリー ジェノミクス カンパニー リミテッドＢｅｒｒｙ Ｇｅｎｏｍｉｃｓ Ｃｏ．， Ｌｔｄ． 胎芽又は腫瘍染色体のコピー数を検出するシステム及び装置
DK2561103T3 (da) 2011-06-29 2014-10-20 Bgi Diagnosis Co Ltd Ikke-invasiv påvisning af føtal genetisk anomali
JP6161607B2 (ja) * 2011-07-26 2017-07-12 ベリナタ ヘルス インコーポレイテッド サンプルにおける異なる異数性の有無を決定する方法
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2886508T3 (es) 2011-10-06 2021-12-20 Sequenom Inc Métodos y procedimientos para la evaluación no invasiva de variaciones genéticas
US20140370504A1 (en) 2011-12-31 2014-12-18 Bgi Diagnosis Co., Ltd. Method for detecting genetic variation
WO2013109981A1 (en) * 2012-01-20 2013-07-25 Sequenom, Inc. Diagnostic processes that factor experimental conditions
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
JP6411995B2 (ja) 2012-03-13 2018-10-24 ザ チャイニーズ ユニバーシティー オブ ホンコン 非侵襲的出生前診断のために大量並列シークエンシング・データを分析する方法
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
CA2878246C (en) 2012-07-20 2022-01-11 Verinata Health, Inc. Detecting and classifying copy number variation in a cancer genome
GB2533006B (en) 2012-09-04 2017-06-07 Guardant Health Inc Systems and methods to detect copy number variation
US10233495B2 (en) 2012-09-27 2019-03-19 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
GB2528205B (en) 2013-03-15 2020-06-03 Guardant Health Inc Systems and methods to detect rare mutations and copy number variation
WO2014204991A1 (en) 2013-06-17 2014-12-24 Verinata Health, Inc. Method for determining copy number variations in sex chromosomes
HUE042654T2 (hu) 2013-06-21 2019-07-29 Sequenom Inc Eljárás genetikai variációk nem-invazív megállapítására
KR102429186B1 (ko) 2013-10-21 2022-08-03 베리나타 헬스, 인코포레이티드 사본수 변동을 결정함에 있어서 검출의 감수성을 향상시키기 위한 방법
US10415083B2 (en) 2013-10-28 2019-09-17 The Translational Genomics Research Institute Long insert-based whole genome sequencing
CA2950596C (en) 2014-05-30 2023-10-31 Verinata Health, Inc. Detecting fetal sub-chromosomal aneuploidies and copy number variations
EP3502273B1 (en) 2014-12-12 2020-07-08 Verinata Health, Inc. Cell-free dna fragment
US10368909B2 (en) 2015-02-26 2019-08-06 Titan Medical Inc. Apparatus for providing access for a surgical procedure
US10095831B2 (en) 2016-02-03 2018-10-09 Verinata Health, Inc. Using cell-free DNA fragment size to determine copy number variations
US11342047B2 (en) 2017-04-21 2022-05-24 Illumina, Inc. Using cell-free DNA fragment size to detect tumor-associated variant

Also Published As

Publication number Publication date
IL245177A0 (en) 2016-06-30
US20160239604A1 (en) 2016-08-18
US10741269B2 (en) 2020-08-11
EP3061021A1 (en) 2016-08-31
AU2014340239A1 (en) 2016-05-12
IL245177B (en) 2019-11-28
AU2020200728C1 (en) 2021-09-09
EP4227947A1 (en) 2023-08-16
CA2928185A1 (en) 2015-04-30
JP6534191B2 (ja) 2019-06-26
AU2020200728A1 (en) 2020-02-20
WO2015061359A1 (en) 2015-04-30
AU2014340239B2 (en) 2019-11-28
KR102429186B1 (ko) 2022-08-03
CN105830077A (zh) 2016-08-03
KR102373647B1 (ko) 2022-03-11
AU2020200728B2 (en) 2021-05-27
KR20220034929A (ko) 2022-03-18
CN105830077B (zh) 2019-07-09
EP3061021B1 (en) 2023-05-10
BR112016008870A8 (pt) 2020-03-24
JP2016539630A (ja) 2016-12-22
KR20160073405A (ko) 2016-06-24

Similar Documents

Publication Publication Date Title
AU2020200728B2 (en) Method for improving the sensitivity of detection in determining copy number variations
US12217827B2 (en) Detecting fetal sub-chromosomal aneuploidies
EP3543354B1 (en) Method for generating a masked reference sequence of the y chromosome
HK40098511A (en) Method for improving the sensitivity of detection in determining copy number variations
HK1228052B (en) Method for improving the sensitivity of detection in determining copy number variations
HK1228052A1 (en) Method for improving the sensitivity of detection in determining copy number variations
HK40033718A (en) Detecting, optionally fetal, sub-chromosomal aneuploidies and copy number variations
HK40013205B (en) Method for generating a masked reference sequence of the y chromosome
HK40013205A (en) Method for generating a masked reference sequence of the y chromosome
HK1235436B (en) Detecting, optionally fetal, sub-chromosomal aneuploidies and copy number variations
HK1235436A1 (en) Detecting, optionally fetal, sub-chromosomal aneuploidies and copy number variations
BR112016008870B1 (pt) Método e sistema para avaliação de número de cópias de uma sequência de ácidos nucleicos de interesse em uma amostra de teste, e, método para criar um mascarador de sequência
HK1223988B (en) Method for determining copy number variations in sex chromosomes

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190916

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251001

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251208

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260113

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260113